Pharmaceutical

EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma

BeOne Medicines has secured approval from the EC for Tevimbra (tislelizumab) to ...

FDA publishes more than 200 archived CRLs for transparency

The FDA has issued more than 200 complete response letters, which detail reasons...

The unsustainability of clinical trials and need for tr...

With clinical trials under pressure, industry leaders say it’s time for reform, ...

IGI and AbbVie sign licence deal for cancer and autoimm...

IGI Therapeutics has signed an exclusive licensing agreement with AbbVie, for IS...

FDA gives TSND-201 breakthrough therapy designation for...

Transcend Therapeutics announced that the FDA has granted breakthrough therapy d...

Enhancing solubility of targeted protein degraders: Bet...

Achieving good oral bioavailability for targeted protein degraders (TPDs) is vit...

CTO East Coast 2025: Global oncology cell therapy marke...

The US dominates overall sales, yet GlobalData predicts that China is shaping up...

How to remain a top CDMO in ADC-led oncology

Amid new regulations, changes in tariffs, supply chain disruptions, we look at h...

Lupin and Zentiva in licence and supply deal for Certol...

Zentiva Group has entered a licence and supply agreement with Lupin for the comm...

Merck agrees to acquire Verona Pharma for $10bn

Merck has entered a definitive agreement to acquire biopharmaceutical company Ve...

Real-world evidence as a strategic access lever in rare...

In a recent webinar, industry experts explain how real-world data and patient-ce...

CTO East Coast 2025: Navigating shifting regulatory env...

A panel at CTO East Coast discussed the regulatory changes impacting oncology tr...

Research warns of rising HIV cases in Africa amid globa...

Global funding cuts, including those made by the Trump administration, are set t...

Swissmedic approves IFINWIL for children with high-risk...

Swissmedic approved the registration of IFINWIL (eflornithine) as a monotherapy ...

Chugai and Gero link on antibody drugs for age-related ...

Chugai signed a joint research and licencing agreement with Singapore-based biot...